Alexion has routinely featured among lists of top biopharma takeover prospects in the last couple of years, and that was a good call – AstraZeneca has just swooped in with $39 billion cash-and ...

Recursion Pharma has agreed to merge with rival AI-powered drug discovery firm Exscientia in an all-stock deal valued at $688 million ...

The latest news and investigations from the Middle East, including Iraq, Israel, Lebanon, UAE, Iran, Syria, Saudi Arabia and Jordan.